<?xml version="1.0" encoding="UTF-8"?>
<p id="p0430" num="0430" sourceFile="EP 1828185B1.xml">The title compound was prepared from 
  <i>N</i>-{3-[3-(2-chloro-4-pyrimidinyl)pyrazolo[1,5-a]pyridin-2-yl]phenyl}-2,6-difluorobenzamide and 4-chloro-4-3-trifluoromethyl-aniline in a manner analogous to 
  <b>Example 27</b>, Step D. 
  <sup>1</sup>H NMR (400 MHz, DMSO-d
  <sub>6</sub>) δ 6.70 (d, 1H, J = 5.4 Hz), 7.19 (t, 1H, J = 6.9 Hz), 7.29 (t, 2H, J = 8.0 Hz), 7.49-7.63 (m, 5H), 7.85 (d, 1 H, J = 9.0 Hz), 8.01 (d, J = 2.1 Hz, 1 H), 8.06 (s, 1 H), 8.38-8.40 (m, 2H), 8.46 (d, 1H, J = 8.9 Hz), 8.91 (d, 1H, J = 6.9 Hz), 10.08 (s, 1 H), 10.97 (s, 1 H); ESIMS (M+H)
  <sup>+</sup> = 621.
</p>
